Eli Lilly Japan and Mitsubishi Tanabe Pharma Corporation signed a sales collaboration agreement in Japan for GIP/GLP-1 receptor agonist “Tirzepatide”
July 7, 2022
Mitsubishi Tanabe Pharma Corporation, a member of the Mitsubishi Chemical Group, has announced the following press release.
■Mitsubishi Tanabe Pharma Press Release
■Mitsubishi Tanabe Pharma Press Release
Eli Lilly Japan and Mitsubishi Tanabe Pharma Corporation signed a sales collaboration agreement in Japan for GIP/GLP-1 receptor agonist “Tirzepatide”
https://www.mt-pharma.co.jp/e/news/assets/pdf/e_MTPC220707.pdf